Aug 26 (Reuters) – U.S. President Donald Trump’s administration is planning to announce a new round of drug-pricing agreements with midsize biotech companies on Monday, Bloomberg News reported on Wednesday, citing people familiar to the matter.
Reuters could not immediately verify the report.
(Reporting by Gargi Gupta in Bengaluru, Editing by Franklin Paul)
Comments